American Association of Neuromuscular & Electrodiagnostic Medicine 2026 (AANEM)

Back

HARMONIA Study Design: A Global Phase 3 Trial Assessing the Efficacy and Safety of Zeleciment Basivarsen in Myotonic Dystrophy Type 1 (DM1) (poster)

HARMONIA Study Design: A Global Phase 3 Trial Assessing the Efficacy and Safety of Z-basivarsen in Myotonic Dystrophy Type 1 (presentation)

Long-Term Functional Improvement With Zeleciment Basivarsen in the Phase 1/2 ACHIEVE Trial (poster)

Long-Term Functional Improvement With Zeleciment Basivarsen in the Phase 1/2 ACHIEVE Trial (supplemental data)

Zeleciment Rostudirsen Led to Trends in Long-term Improvement in Clinical Outcomes Including Cardiopulmonary Function (poster)

Zeleciment Rostudirsen Significantly Increased Dystrophin Protein Levels and Led to Functional Improvement in Clinical Measures in the DELIVER Trial (poster)

Zeleciment Rostudirsen Significantly Increased Dystrophin Protein Levels and Led to Functional Improvement in Clinical Measures in the DELIVER Trial (supplemental data)